secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2025-01-06T23:59:59+00:00
Accession:  0001171843-25-000051
Event type: m_and_a
Sentiment:  positive
Materiality: 0.90
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology agrees to be acquired by Renovaro for $3.00/share in preferred stock
--------------------------------------------------------------------------------

- POAI shareholders to receive 1 share of Renovaro preferred stock per POAI share, redeemable for $3.00 after 18 months.
- Preferred stock convertible to Renovaro common at 1:1 after RENB trades at $4.50+ for 30 consecutive days.
- Renovaro to purchase up to 2.33M POAI shares at $1.07 if warrants unexercised by Jan 15, 2025.
- Merger conditioned on Renovaro raising $15M and POAI shareholder approval; definitive docs by Feb 28, 2025.
- Combined company expects >30% near-term operating expense reduction via AI/ML platform synergies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184325000051/0001171843-25-000051-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184325000051/f8k_010625.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-000051

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer